DiCE Molecules
Elke Augustino currently serves as an IT Trainer and Communications specialist at DICE Therapeutics, Inc., a subsidiary of Eli Lilly and Company, where employment began in June 2022. Prior to this, Elke Augustino worked at Theravance from January 2006 to 2021 as an IT&I Systems Trainer. Educational qualifications include a degree from California Polytechnic State University-San Luis Obispo, attended from 1989 to 1994.
DiCE Molecules
DiCE Molecules designs and develops innovative therapies in immunology for patients with debilitating disease. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, they are developing oral alternatives to medicines currently limited to injectable forms.